An Alluring Acquisition Proposal Is Raising Pasithea (KTTA) Stock Up 26% Today
Pasithea Therapeutics Corp. (NASDAQ: KTTA) surged by a remarkable 26% to $0.5040 during early trading on Monday. In the previous session, KTTA witnessed a substantial increase of 14.29%, closing at $0.40. The biotechnology company, specializing in groundbreaking medical advancements, has attracted significant attention following an acquisition offer. Who Made Proposal To Acquire KTTA? Lucy Scientific […]
